This infers that this pathway is mostly inactivated by mechanisms resulting from molecular events other than the somatic mutations of the pathway genes, thereby intimating to the role of epigenetic modifiers like Cbx7, which are also circumvented in glioma. The gene discussed is CBX7; the disease is glioma.